392
Participants
Start Date
November 30, 2012
Primary Completion Date
January 31, 2014
Study Completion Date
April 30, 2014
TD-9855 Group 1
TD-9855 Group 2
Placebo
Upstate Clinical Research Associates, LLC, Williamsville
Altoona Center for Clinical Research, Duncansville
The Center for Clinical Research, Winston-Salem
Wake Research Associates, Raleigh
Coastal Carolina Research Center, Mt. Pleasant
Carolina Center for Rheumatology & Arthritis Care, Rock Hill
Compass Research, LLC, Orlando
PAB Clinical Research, Brandon
Meridien Research, Lakeland
Florida Clinical Research Center, LLC, Bradenton
Renstar Medical Research, Ocala
Rheumatology Associates of North Alabama, PC, Huntsville
ClinSearch, LLC, Chattanooga
Clinical Research Source, Inc., Perrysburg
University of Cincinnati, Cincinnati
MediSphere Medical Research Center, LLC, Evansville
Meridian Clinical Research, Dakota Dunes
Lillestol Research, LLC, Fargo
Clinical Investigation Specialists, Inc., Gurnee
The Center for Pharmaceutical Research, Kansas City
GTC Research, Shawnee Mission
Meridian Clinical Research, Omaha
Tulsa Clinical Research, LLC, Tulsa
Dedicated Clinical Research, Goodyear
Advanced Biomedical Research of America, Las Vegas
TriWest Research Associates, LLC, El Cajon
Arroyo Medical Group, Inc., Pismo Beach
Diablo Clinical Research, Inc., Walnut Creek
Sunstone Medical Research, LLC, Medford
Swedish Rheumatology Research, Seattle
Coastal Connecticut Research, LLC, New London
Beacon Clinical Research, Brockton
Beacon Clinical Research, New Bedford
Omega Medical Research, Warwick
Lead Sponsor
Theravance Biopharma
INDUSTRY